RecruitingNCT06713993

Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer

Noninvasive Testing Procedures, Role of Biomarkers and Anticancer Treatments in Esophageal and Esophagogastric Cancer Survival and Quality of Life of Patients With Cancer of the Esophageopharyngeal and Oesophageophageophageal Junction


Sponsor

Semmelweis University

Enrollment

100 participants

Start Date

Sep 10, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of this observational study was to gain a deeper understanding of the epidemiology of the disease in Hungary through a broad analysis of patients with new-onset esophageal-oesophageal-stomach junction tumors, and to identify key parameters that could potentially influence the outcome of the disease and are closely correlated with morbidity and mortality. The investigators' primary objective is to identify potential factors and conditions that could be influenced and modified to enhance the disease outcome. Main questions: 1. What are the measurable changes in performance, workload, nutritional status, cardiac function, mental status in the patients studied? 2. What is the time course of the changes during and after treatment? 3. Which pathological parameters are associated with disease outcome and which are potential points of intervention to improve the course of the disease? Patients will undergo a detailed physical and nutritional assessment, non-invasive imaging tests and several questionnaires in addition to the usual pre- and post-operative examinations.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study collects non-invasive measurements — such as imaging, blood tests, and other biomarkers — from patients with esophageal or esophagogastric junction cancer before surgery, to identify which markers can predict how well patients will do after their operation. **You may be eligible if...** - You are over 18 years old - You have a newly diagnosed esophageal or esophagogastric junction tumor - You are scheduled for curative surgery (open or laparoscopic) - You have not yet started any oncological treatment for this cancer **You may NOT be eligible if...** - You are unwilling or unable to give consent - You are unable to cooperate with study procedures - You have a contraindication to MRI (in which case the cardiac MRI portion would be skipped) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Semmelweis University

Budapest, Hungary

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06713993


Related Trials